Weekly CSR Email Newsletter
CSR Assessments and Training in China!Compliance and Sustainability are two sides of the same coin, and businesses must keep their suppliers aware of key concepts to ensure that a business maintains best practices in China. Clear goals, ethics and mission starts with YOU! Find Out More Here.
Distribute Press Releases To Chinese Media!Getting your company's message to journalists is important in China and ChinaNewswire.com can assist you in English-language releases and Xinwengao.com can provide Chinese-language distribution services. Corporate press releases are the most cost-effective way for you to connect with your customers and stakeholders in China!
• Green Building China 2009 @ Beijing - 2009/11/04
Let us work with you in China to manage your email marketing campaigns, loyalty marketing programs, email newsletters, and digital marketing efforts while we improve your email deliverability in China. Our software and staff can help your company stay #1! Visit XZList.com
AMDL Hopes For China Approval Of Anti-Cancer Drug
February 13, 2007 |
Print
| 
Email
| Category: Health
AMDL, a developer of tests for the early detection of cancer and other serious diseases, says that Jade Pharmaceuticals, its wholly-owned subsidiary in China, has set up production and applied for China State Food and Drug Administration approval to market Docetaxel in China.
Docetaxel is an anti-cancer drug that interferes with the growth of cancer cells.
"There is an enormous need in China for effective and affordable cancer drugs, with more than 1.6 million new cases of the disease annually," said Gary Dreher, AMDL CEO. "Docetaxel is extremely useful because it can treat a broad spectrum of cancers, including breast cancer, non-small cell lung cancer, stomach cancer and prostate cancer."
According to the company, Docetaxel currently generates more than US$2 billion in sales globally at a rate increasing 20% annually. This drug currently represents approximately US$200 million in sales in China.
According to Dreher, Docetaxel is currently the most popular anticancer drug in China.
Rate this page: 
Loading ...Leave A Comment:
-
Energy & Cleantech
-
Environment
- Mainland And Hong Kong Work On Environmentally-friendly Paper
- PepsiCo Opens First Overseas 'Green' Plant In China
- Chinese Official Suggests Abolishing Disposable Wooden Chopsticks
- Retail Markets In China Face Punishment Over Substandard Plastic Bags
- China First Heavy Industries Fined For Infringement Of Environmental Rules
-
Giving
-
Law & Order
-
Viewpoints
- Companies Can Help In The March Towards Better Consumer Rights In China
- CSR Review: Companies Have More Opportunities To Develop In China
- How Far Can Chinese Companies Take Corporate Social Responsibility?
- CSR Review: Companies Focus On Sustainability In China During Downturn
- Global Financial Woes May Impact Corporate Social Responsibility In China
Copyright 2003-2009 ChinaCSR.com. All Rights Reserved.
If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website, in whole or in part, is expressly prohibited without express written permission from BDL Media.
